🇺🇸 FDA
Pipeline program

Epoetin alga (Epogen)/vadadustat

USRC-2026-001

Phase 3 small_molecule active

Quick answer

Epoetin alga (Epogen)/vadadustat for Anemia Associated With Chronic Kidney Disease is a Phase 3 program (small_molecule) at Akebia Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Akebia Therapeutics
Indication
Anemia Associated With Chronic Kidney Disease
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials